Trial updates in prostate cancer from ASCO 2021: VISION, PEACE1, & SWOG S1216 Published 2021-07-02 Download video MP4 360p Download video MP4 720p Recommendations 03:25 Should You Get a Second Opinion on Gleason 6 Pathology Slides? | Expert Laurence Klotz, MD | PCRI 06:24 Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prosta... 08:31 Recent updates in prostate cancer: STAMPEDE, VISION & PROfound 16:11 PEACE-1 trial results with Dr. Alberto Bossi 06:12 PEACE-1 trial 01:56 ARASENS: dialuramide plus ADT and docetaxel for metastatic hormone-sensitive prostate cancer 03:46 Overview of RAPIDO trial in rectal cancer and FOxTROT trial in colon cancer 09:02 Preoperative CRT improves overall survival in pancreatic cancer: long-term results of PREOPANC 02:06 Variability in genomic testing among prostate cancer care providers 05:27 PEACE-1: 8-month PSA determines outcomes in men with mCSPC 1:44:38 ❗️ ВОРОГ ВІЗЬМЕ ХАРКІВЩИНУ?🥺АВДІЇВКА: тримали 10 років, чому віддали❓ 👉 Суботній політклуб 03:09 How can radiotherapy make prostate cancer more immunogenic? 02:24 SPPORT: ADT and salvage radiotherapy in prostate cancer 01:24 The emerging benefits of adjuvant checkpoint inhibition in RCC 01:41 Current and emerging applications for ctDNA analysis in prostate cancer 01:19 Comparing Abiraterone and Docetaxel in Prostate Cancer Treatment 02:23 Which patients with prostate cancer benefit from radiotherapy and hormonal therapy? 1:39:38 Appendiceal cancer is not the same as colon cancer: Implications for chemotherapy 01:41 The role of triplet therapy in men with metastatic castration sensitive prostate cancer 03:41 ASCO GU 2024 highlights: BRCAAway, CONTACT-2 and KEYNOTE-564 Similar videos 03:41 SWOG S1216: ADT and TAK700 in prostate cancer 02:30 Prostate cancer updates at ASCO 2021 03:09 Prostate cancer updates at ESMO 2021: STAMPEDE and PEACE-1 07:44 Promising Studies In Prostate Cancer | A 2021 ASCO Update | Mark Scholz, MD 11:51 Expert Video Report on castration sensitive and resistant prostate cancer - 2021 ASCO Annual Meeting 31:33 2021 ASCO Direct Jacksonville | Prostate Cancer Summary | Dr. William Kelly 03:56 VISION: 177Lu-PSMA-617 in PSMA-positive mCRPC 06:25 Practice-changing data from ESMO 2021 in prostate cancer 33:50 Advances in prostate cancer in the last 10 years and a glimpse to the future 07:14 VISION study 06:11 Prostate and bladder highlights at ESMO 2021 06:45 177Lu-PSMA-617 for prostate cancer: TheraP, VISION, UpFrontPSMA and LuTectomy 18:13 ASCO 2021: Precision and molecular reporting for prostate cancer 05:59 PEACE-1 points to benefit of adding abiraterone to ADT–docetaxel in de novo mCSPC | Karim Fizazi 04:02 2021 ASCO Direct St. Louis | Prostate Cancer Summary | Dr. David VanderWeele 1:00:30 Webinar: Prostate Cancer and Early Detection ASCO 2021 25:53 Developments in metastatic hormone-sensitive prostate cancer More results